KIDNEY DAMAGE IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

The aim of the review is to present the most common renal complications after HSCT such as acute kidney injury, chronic kidney disease glomerulopathies. HSCT is a critical therapy for many cancer patients with cancer, as well as patients with some other nonmalignant hematologic disorders and certain congenital immune deficiencies. Kidney complications after HSCT in a form of acute kidney injury is associated with significant morbidity and worse patient outcome. In addition, risk of chronic kidney disease is also increased following HSCT. It is very important to be aware, prevent, early recognize and treat renal damage to improve kidney and patient survival.

[1]  G. Basak,et al.  Kidney dysfunction after hematopoietic cell transplantation-Etiology, management, and perspectives. , 2018, Hematology/oncology and stem cell therapy.

[2]  U. Heemann,et al.  Renal dysfunction following bone marrow transplantation , 2017, Journal of Nephrology.

[3]  K. Nitta,et al.  Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation , 2016, Nephron.

[4]  K. Ohashi,et al.  Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis. , 2016, Human pathology.

[5]  J. Crawford,et al.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.

[6]  M. Troxell,et al.  Hematopoietic Stem Cell Transplantation: Graft Versus Host Disease and Pathology of Gastrointestinal Tract, Liver, and Lung , 2014, Advances in anatomic pathology.

[7]  M. Troxell,et al.  Renal Pathology Associated With Hematopoietic Stem Cell Transplantation , 2014, Advances in anatomic pathology.

[8]  Y. Liao,et al.  Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience , 2014, International Urology and Nephrology.

[9]  A. Barbouti,et al.  GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation , 2013, Bone Marrow Transplantation.

[10]  B. Chung,et al.  De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience , 2013, Kidney research and clinical practice.

[11]  B. Rovin,et al.  Kidney complications of hematopoietic stem cell transplantation. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  J. Lopes,et al.  Acute kidney injury following HCT: incidence, risk factors and outcome , 2011, Bone Marrow Transplantation.

[13]  A. Ghavamzadeh,et al.  Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes. , 2009, Transplantation proceedings.

[14]  Jonathan C. Cheng,et al.  Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation. , 2008, International journal of radiation oncology, biology, physics.

[15]  D. Weisdorf,et al.  Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  S. Mineishi,et al.  Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant , 2007, Bone Marrow Transplantation.

[17]  S. Hingorani.  Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  C. Parikh,et al.  Acute renal failure in hematopoietic cell transplantation. , 2006, Kidney international.

[19]  R. Storb,et al.  Chronic Kidney Disease Following Non‐Myeloablative Hematopoietic Cell Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  W. McClellan,et al.  Epidemiology and risk factors for chronic kidney disease. , 2005, The Medical clinics of North America.

[21]  M. Sorror,et al.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  R. Soiffer,et al.  Renal failure associated with cancer and its treatment: an update. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  M. Maris,et al.  Acute renal failure after nonmyeloablative hematopoietic cell transplantation. , 2004, Journal of the American Society of Nephrology : JASN.

[24]  M. Boeckh,et al.  ADENOVIRUS NEPHRITIS IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION , 2004, Transplantation.

[25]  Je-Hwan Lee,et al.  Graft‐versus‐host disease (GVHD)‐specific survival and duration of systemic immunosuppressive treatment in patients who developed chronic GVHD following allogeneic haematopoietic cell transplantation , 2003, British journal of haematology.

[26]  P. Gomez-Garcia,et al.  Renal involvement in chronic graft-versus-host disease: a report of two cases. , 1988, Bone marrow transplantation.

[27]  S. Hingorani,et al.  Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: monitoring and management guidelines. , 2012, Seminars in hematology.

[28]  L. DeLeve.  Sinusoidal Obstruction Syndrome (Hepatic Venoocclusive Disease) , 2004 .

[29]  C. Lawton,et al.  Bone marrow transplant nephropathy: radiation nephritis revisited. , 1995, Nephron.

[30]  C. Lawton,et al.  Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients. , 1992, International journal of radiation oncology, biology, physics.